Anne completed her PhD at the Toulouse Purpan Physiopathology Center (INSERM U563, CPTP, Toulouse) under the supervision of Dr Muriel Laffargue during which I studied the role of phosphoinositide 3-kinase gamma (PI3Kγ) dependent signaling in arterial pathologies, particularly atherosclerosis and its complications. She then completed her first post-doctoral fellowship in the team of Dr. Alexey Pshezhetsky at the CHU Sainte-Justine Research Center in Montreal where she worked on the regulation of insulin signaling by neuraminidases. Since 2017, Anne joined the TIM team to perform a second post-doc and obtained in 2018 an Agreenskills funding. Her project consisted in better understanding the transcriptional control of ketogenesis and hepatokine FGF21, two vital functions performed by the liver. Anne was recruited to the team in September 2021 and is currently developing a project combining in vitro and in vivo approaches to study the hepatic and systemic effects of dietary nutrients and contaminants and to identify the mechanisms involved.